2001
DOI: 10.33588/rn.3305.2001185
|View full text |Cite
|
Sign up to set email alerts
|

Cambios en los niveles de factor de crecimiento nervioso con el envejecimiento y el tratamiento neurotrófico en primates no humanos

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2008
2008

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Interestingly, sortilin exhibits the highest accumulation with ongoing development of the forebrain (Hermans-Borgmeyer et al 1999). Some results support the idea that NTs are promising candidates for improving remyelination and thus ameliorating MS. A critical point for making a treatment with neurotrophins effective is the need to achieve a local concentration in a range of 1-10 ng/ml, which is way beyond the endogenous level (pg range; Lorigados et al 2001). Several possibilities exist to circumvent the bloodbrain barrier, which is impermeable for NTs under normal conditions (Althaus 2004;Blesch 2006).…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, sortilin exhibits the highest accumulation with ongoing development of the forebrain (Hermans-Borgmeyer et al 1999). Some results support the idea that NTs are promising candidates for improving remyelination and thus ameliorating MS. A critical point for making a treatment with neurotrophins effective is the need to achieve a local concentration in a range of 1-10 ng/ml, which is way beyond the endogenous level (pg range; Lorigados et al 2001). Several possibilities exist to circumvent the bloodbrain barrier, which is impermeable for NTs under normal conditions (Althaus 2004;Blesch 2006).…”
Section: Resultsmentioning
confidence: 99%